nifedipine has been researched along with glucagon-like peptide 1 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adner, N; Gutniak, M; Holst, JJ; Svartberg, J | 1 |
| Prentki, M; Roche, E; Schlegel, W; Susini, S | 1 |
| Yada, T; Yaekura, K; Yanagida, K | 1 |
| Buteau, J; Prentki, M; Roduit, R; Susini, S | 1 |
| Gribble, FM; Habib, AM; Parker, HE; Ramzan, A; Reimann, F; Rogers, GJ; Tolhurst, G | 1 |
| Chimerel, C; Gribble, FM; Murison, K; Reimann, F; Riccio, C | 1 |
1 trial(s) available for nifedipine and glucagon-like peptide 1
| Article | Year |
|---|---|
The ethanol augmentation of glucose-induced insulin secretion is abolished by calcium antagonism with nifedipine: no evidence for a role of glucagon-like peptide-1 (GLP-1).
Topics: Adult; C-Peptide; Calcium Channel Blockers; Ethanol; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Male; Nifedipine; Peptide Fragments; Protein Precursors | 1998 |
5 other study(ies) available for nifedipine and glucagon-like peptide 1
| Article | Year |
|---|---|
Glucose and glucoincretin peptides synergize to induce c-fos, c-jun, junB, zif-268, and nur-77 gene expression in pancreatic beta(INS-1) cells.
Topics: Animals; Cell Line; Cyclic AMP; DNA-Binding Proteins; Drug Synergism; Early Growth Response Protein 1; Gastric Inhibitory Polypeptide; Gene Expression Regulation; Genes, fos; Genes, Immediate-Early; Genes, jun; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Immediate-Early Proteins; Islets of Langerhans; Neuropeptides; Nifedipine; Peptide Fragments; Pituitary Adenylate Cyclase-Activating Polypeptide; Protein Precursors; Recombinant Proteins; Tetradecanoylphorbol Acetate; Thionucleotides; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Zinc Fingers | 1998 |
PACAP and GLP-1 protect islet beta-cells against Ca2+ toxicity induced by high K+.
Topics: Animals; Arginine; Calcium; Cells, Cultured; Glucagon; Glucagon-Like Peptide 1; Glucose; Islets of Langerhans; Neuropeptides; Nifedipine; Peptide Fragments; Pituitary Adenylate Cyclase-Activating Polypeptide; Potassium Chloride; Protein Precursors; Rats; Rats, Wistar; Tolbutamide | 1998 |
Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells.
Topics: Androstadienes; Animals; Chromones; DNA; DNA-Binding Proteins; Duodenum; Enzyme Activation; Enzyme Inhibitors; Genes, Homeobox; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Insulin; Islets of Langerhans; Morpholines; Nifedipine; Pancreas; Peptide Fragments; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Potassium Chloride; Protein Precursors; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction; Transcription Factor AP-1; Transcription Factors; Tumor Cells, Cultured; Wortmannin | 1999 |
Electrical activity-triggered glucagon-like peptide-1 secretion from primary murine L-cells.
Topics: Action Potentials; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Electric Stimulation; Electrophysiology; Enteroendocrine Cells; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Glucagon-Like Peptide 1; Ion Channel Gating; Mice; Mice, Transgenic; Nifedipine; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Optogenetic Analysis of Depolarization-Dependent Glucagonlike Peptide-1 Release.
Topics: 1-Methyl-3-isobutylxanthine; Action Potentials; Animals; Calcium; Calcium Channel Blockers; Colforsin; Enteroendocrine Cells; Glucagon-Like Peptide 1; Membrane Potentials; Mice; Nifedipine; omega-Conotoxin GVIA; Optogenetics; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Rhodopsin; Sodium Channel Blockers; Tetrodotoxin; Vasodilator Agents | 2017 |